|
Volumn 121, Issue 27, 2001, Pages 3160-3162
|
The clinical significance of maternal alloantibodies in thrombocytopenia of the new-born;Maternelle alloantistoffers betydning ved trombocytopeni hos nyfødte
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALLOANTIBODY;
HLA ANTIBODY;
HUMAN PLATELET ANTIGEN 1A ANTIBODY;
HUMAN PLATELET ANTIGEN 1BB;
MATERNAL ANTIBODY;
THROMBOCYTE ANTIBODY;
THROMBOCYTE ANTIGEN;
UNCLASSIFIED DRUG;
IMMUNOGLOBULIN G;
ALLOIMMUNITY;
ANTIBODY DETECTION;
ARTICLE;
CONTROLLED STUDY;
COST BENEFIT ANALYSIS;
DISEASE SEVERITY;
FEMALE;
FETUS;
GENOTYPE;
HUMAN;
LABORATORY TEST;
MAJOR CLINICAL STUDY;
NEWBORN;
NEWBORN SCREENING;
PREGNANCY;
THROMBOCYTE;
THROMBOCYTOPENIA;
TRANSFUSION;
BLOOD;
FETOMATERNAL TRANSFUSION;
GENE;
GENETICS;
IMMUNOLOGY;
ANTIGENS, HUMAN PLATELET;
BLOOD PLATELETS;
FEMALE;
GENES, MHC CLASS I;
HUMANS;
IMMUNOGLOBULIN G;
INFANT, NEWBORN;
ISOANTIBODIES;
MATERNAL-FETAL EXCHANGE;
PREGNANCY;
THROMBOCYTOPENIA;
|
EID: 0035841531
PISSN: 00292001
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (9)
|
References (15)
|